Literature DB >> 28870616

miR-16: expanding the range of molecular targets in mesothelioma.

Dean Fennell1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28870616     DOI： 10.1016/S1470-2045(17)30596-X

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

Review 1.  microRNAs Tune Oxidative Stress in Cancer Therapeutic Tolerance and Resistance.

Authors:  Wen Cai Zhang
Journal:  Int J Mol Sci       Date:  2019-12-03       Impact factor: 5.923

2.  Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma.

Authors:  Barbara Marengo; Alessandra Pulliero; Maria Valeria Corrias; Riccardo Leardi; Emanuele Farinini; Gilberto Fronza; Paola Menichini; Paola Monti; Lorenzo Monteleone; Giulia Elda Valenti; Andrea Speciale; Patrizia Perri; Francesca Madia; Alberto Izzotti; Cinzia Domenicotti
Journal:  J Pers Med       Date:  2021-02-07

Review 3.  mTOR signaling-related MicroRNAs and Cancer involvement.

Authors:  Ping Wang; Xiao-Min Liu; Lei Ding; Xin-Ju Zhang; Zhong-Liang Ma
Journal:  J Cancer       Date:  2018-01-08       Impact factor: 4.207

4.  MicroRNA-16 regulates lipopolysaccharide-induced inflammatory factor expression by targeting TLR4 in normal human bronchial epithelial cells.

Authors:  Xiaobo Li; Qian Chu; Huaqi Wang
Journal:  Exp Ther Med       Date:  2021-07-12       Impact factor: 2.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.